Oxbow Advisors LLC Increases Position in Anthem Inc (NYSE:ANTM)
Oxbow Advisors LLC boosted its holdings in shares of Anthem Inc (NYSE:ANTM) by 1.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 14,516 shares of the company’s stock after purchasing an additional 237 shares during the period. Oxbow Advisors LLC’s holdings in Anthem were worth $4,384,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also bought and sold shares of the company. Sonora Investment Management LLC acquired a new position in Anthem during the fourth quarter valued at $30,000. CFM Wealth Partners LLC acquired a new position in Anthem during the fourth quarter valued at $31,000. Evolution Wealth Advisors LLC lifted its position in Anthem by 973.3% during the fourth quarter. Evolution Wealth Advisors LLC now owns 161 shares of the company’s stock valued at $49,000 after purchasing an additional 146 shares during the period. Private Ocean LLC lifted its position in Anthem by 72.8% during the fourth quarter. Private Ocean LLC now owns 178 shares of the company’s stock valued at $54,000 after purchasing an additional 75 shares during the period. Finally, Horan Capital Advisors LLC. acquired a new position in Anthem during the third quarter valued at $43,000. Institutional investors own 88.27% of the company’s stock.
In related news, EVP Thomas C. Zielinski sold 10,600 shares of the company’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $288.33, for a total transaction of $3,056,298.00. Following the completion of the transaction, the executive vice president now owns 35,247 shares in the company, valued at approximately $10,162,767.51. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Gail Boudreaux purchased 7,600 shares of Anthem stock in a transaction that occurred on Thursday, January 30th. The shares were bought at an average price of $266.65 per share, with a total value of $2,026,540.00. Following the transaction, the chief executive officer now owns 24,556 shares in the company, valued at $6,547,857.40. The disclosure for this purchase can be found here. 0.17% of the stock is owned by corporate insiders.
Anthem (NYSE:ANTM) last issued its quarterly earnings data on Wednesday, January 29th. The company reported $3.88 earnings per share for the quarter, missing analysts’ consensus estimates of $3.90 by ($0.02). The firm had revenue of $27.13 billion during the quarter, compared to analyst estimates of $27.06 billion. Anthem had a return on equity of 16.34% and a net margin of 4.61%. The company’s revenue was up 16.4% on a year-over-year basis. During the same quarter last year, the company posted $2.44 EPS. As a group, sell-side analysts predict that Anthem Inc will post 22.41 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, March 27th. Investors of record on Monday, March 16th will be given a dividend of $0.95 per share. This represents a $3.80 annualized dividend and a dividend yield of 1.28%. The ex-dividend date of this dividend is Friday, March 13th. This is an increase from Anthem’s previous quarterly dividend of $0.80. Anthem’s dividend payout ratio is 16.46%.
ANTM has been the subject of a number of research reports. Bank of America decreased their target price on shares of Anthem from $330.00 to $324.00 and set a “neutral” rating for the company in a research report on Thursday, January 30th. Credit Suisse Group decreased their price objective on shares of Anthem from $380.00 to $355.00 and set an “outperform” rating for the company in a research report on Friday, January 31st. Stephens decreased their price objective on shares of Anthem from $345.00 to $330.00 and set an “overweight” rating for the company in a research report on Wednesday, January 29th. Deutsche Bank decreased their price objective on shares of Anthem from $319.00 to $314.00 and set a “buy” rating for the company in a research report on Friday, January 31st. Finally, JPMorgan Chase & Co. upped their price objective on shares of Anthem from $322.00 to $391.00 and gave the stock an “overweight” rating in a research report on Friday, December 20th. Five investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $325.77.
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.
Featured Story: Buy Rating
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.